Triple negative breast cancer (TNBC) is one of the most aggressive and hardest forms of breast cancer to treat, but a new ...
A Weill Cornell Medicine team has found that triple-negative breast cancer depends on the enzyme EZH2 to spread. By silencing key genes, EZH2 drives chaotic cell divisions and fuels metastasis.
Companies borrowed a record $207B in the US investment-grade market in Sept., more than Wall Street's top underwriter of the ...